These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 25645642)

  • 1. Attention deficit/hyperactivity disorder and interictal epileptiform discharges: it is safe to use methylphenidate?
    Socanski D; Aurlien D; Herigstad A; Thomsen PH; Larsen TK
    Seizure; 2015 Feb; 25():80-3. PubMed ID: 25645642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Aggravation of Seizures and Methylphenidate Treatment in Subjects with Attention-Deficit/Hyperactivity Disorder and Epilepsy.
    Park J; Choi HW; Yum MS; Ko TS; Shon SH; Kim HW
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):537-546. PubMed ID: 30089215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.
    Baptista-Neto L; Dodds A; Rao S; Whitney J; Torres A; Gonzalez-Heydrich J
    Expert Opin Investig Drugs; 2008 Jan; 17(1):77-84. PubMed ID: 18095920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epilepsy in a large cohort of children diagnosed with attention deficit/hyperactivity disorders (ADHD).
    Socanski D; Aurlien D; Herigstad A; Thomsen PH; Larsen TK
    Seizure; 2013 Oct; 22(8):651-5. PubMed ID: 23711613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review.
    Koneski JA; Casella EB; Agertt F; Ferreira MG
    Epilepsy Behav; 2011 Jul; 21(3):228-32. PubMed ID: 21524941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.
    van der Feltz-Cornelis CM; Aldenkamp AP
    Epilepsy Behav; 2006 May; 8(3):659-62. PubMed ID: 16504592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
    Torres AR; Whitney J; Gonzalez-Heydrich J
    Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing therapy of seizures in children and adolescents with ADHD.
    Aldenkamp AP; Arzimanoglou A; Reijs R; Van Mil S
    Neurology; 2006 Dec; 67(12 Suppl 4):S49-51. PubMed ID: 17190923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention deficit and hyperactivity disorder in people with epilepsy: diagnosis and implications to the treatment.
    Koneski JA; Casella EB
    Arq Neuropsiquiatr; 2010 Feb; 68(1):107-14. PubMed ID: 20339664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the electroencephalogram in attention deficit hyperactivity disorder.
    Millichap JG; Millichap JJ; Stack CV
    Clin EEG Neurosci; 2011 Jul; 42(3):180-4. PubMed ID: 21870470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies.
    Santos K; Palmini A; Radziuk AL; Rotert R; Bastos F; Booij L; Fernandes BS
    Dev Med Child Neurol; 2013 Jul; 55(7):654-60. PubMed ID: 23480530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?
    Gross-Tsur V; Manor O; van der Meere J; Joseph A; Shalev RS
    J Pediatr; 1997 Apr; 130(4):670-4. PubMed ID: 9432523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?
    Gross-Tsur V; Manor O; van der Meere J; Joseph A; Shalev RS
    J Pediatr; 1997 Jan; 130(1):40-4. PubMed ID: 9003849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADHD in childhood epilepsy: Clinical determinants of severity and of the response to methylphenidate.
    Rheims S; Herbillon V; Villeneuve N; Auvin S; Napuri S; Cances C; Berquin P; Castelneau P; Nguyen The Tich S; Villega F; Isnard H; Nabbout R; Gaillard S; Mercier C; Kassai B; Arzimanoglou A;
    Epilepsia; 2016 Jul; 57(7):1069-77. PubMed ID: 27237724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit.
    Fosi T; Lax-Pericall MT; Scott RC; Neville BG; Aylett SE
    Epilepsia; 2013 Dec; 54(12):2071-81. PubMed ID: 24304474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological management of attention deficit hyperactivity disorder with methylphenidate and atomoxetine within a context of epilepsy].
    Mulas F; Roca P; Ros-Cervera G; Gandía-Benetó R; Ortiz-Sánchez P
    Rev Neurol; 2014 Feb; 58 Suppl 1():S43-9. PubMed ID: 25252667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
    Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
    Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate for attention problems in epilepsy patients: Safety and efficacy.
    Leeman-Markowski BA; Adams J; Martin SP; Devinsky O; Meador KJ
    Epilepsy Behav; 2021 Feb; 115():107627. PubMed ID: 33360744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities.
    Gucuyener K; Erdemoglu AK; Senol S; Serdaroglu A; Soysal S; Kockar AI
    J Child Neurol; 2003 Feb; 18(2):109-12. PubMed ID: 12693777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.